Pabella, Reyjane .

HRN: 27-76-21  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/10/2025
CEFUROXIME 500MG (TAB)
09/10/2025
09/17/2025
PO
500mg
BID
S/P LSCS
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines